Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
about
Muscle relaxants versus placebo for tension-type headache prophylaxisMuscle relaxants versus placebo for tension-type headache prophylaxisItalian guidelines for primary headaches: 2012 revised versionA rational approach to the management of chronic migraine.The prophylactic treatment of chronic daily headache.Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.New developments in migraine prophylaxis.Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily HeadacheGeneral principles of migraine management: the changing role of prevention.Management of chronic daily headache: challenges in clinical practice.Chronic daily headaches.Clinical management of pain in advanced lung cancer.Acupuncture for tension-type headache: a multicentre, sham-controlled, patient-and observer-blinded, randomised trial.Botulinum toxin type A for the treatment of migraine.Pharmacotherapy of tension-type headache (TTH).Current and emerging treatment options for migraine and other primary headache disorders.Treatment of chronic overmedicated headache patients.Levetiracetam in the preventive treatmentof transformed migraine: A prospective, open-label, pilot studyTackling chronic migraine: current perspectives.The Face of Chronic Migraine Which Has Started to be Clarified.Treatment of chronic migraine.Pediatric headache: a clinical review.Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine.Outcome of Chronic Daily Headache or Chronic Migraine.Update on the Pharmacological Treatment of Chronic Migraine.Chronic Daily Headache: Mechanisms and Principles of Management.Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial.Chronic migraine: risk factors, mechanisms and treatment.Treatment Update of Chronic Migraine.Production and stability evaluation of modified-release microparticles for the delivery of drug combinations.Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.Tizanidine is not a cure for chronic daily headache.[Chronic migraine].Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.Predictors of a negative response to topiramate therapy in patients with chronic migraine.Biofeedback therapy for pediatric headache: factors associated with response.Botox therapy for refractory chronic migraine.
P2860
Q24234554-A58EB5B0-C879-44F8-BF30-28D7271B6987Q24240876-1774DDAC-C9F1-421B-8BC4-0552FE7E1B99Q30466790-AEBE2D8C-C787-46C2-99AB-D9567FC29033Q34321114-83172569-1D74-4ECD-A73C-CB50BF178254Q34583067-E29CA903-931A-4D26-9D07-B9A6EE95E8ABQ34619560-CC9EB481-1CF5-4EBD-A618-B4B2C2A79CE2Q35095175-544F0298-C63D-4B44-9B33-E196D83F0B74Q35680421-FE19B4D9-3183-4E78-BF27-473DC751E6B3Q35690766-2319CC19-0817-4C23-9754-C3E9C4F2ABA7Q35697916-3DCDC986-37AA-4C63-A3BA-DA86E7376962Q36099512-EAD73C58-1F6E-4E0C-9087-61B313B71649Q36099528-FC0A2926-D276-43F3-A915-16D4A7F22113Q36239475-5D02A9DD-EC05-4D22-AB8B-0F1297DA884DQ36327481-9D010A06-7249-4D6B-8453-79ED1457059CQ36332465-C639042F-45CC-4379-9F8B-AFCC96E99D30Q36488226-24F95970-800E-4996-9694-481D49702847Q37492582-CD0D70B2-5CBC-47A9-A94C-8E23DBB21372Q37610198-365B8610-B6BF-4531-BBED-314D2007E604Q37610200-B948D8F0-1E7F-4983-B8C7-6C447FB8D458Q37661031-53D634A5-BC33-4BF0-ABC2-09D483AC397CQ37702228-A91B5F3E-CC1C-4BE6-9887-2DE604871BB5Q37703839-F270A946-9336-40B3-94D7-A337D0A88E64Q37809775-1899085A-F8B3-48B1-81AA-C1BA5B776B37Q37979834-9D804B8E-BC41-46E9-B44C-F2104F3F7A71Q38255772-5336D362-7740-4081-9B68-BEDA92E15608Q38569170-8108DBE2-12AF-4CB4-B834-999F801A3171Q38676484-A53220FB-6FB3-4174-AA6A-13B2B376FD3AQ38686130-2BC10598-CD54-4022-A57F-0B39C992185BQ38700966-A9ED3CF2-030B-4B56-864B-42878A7DD31FQ38773592-114FB3A5-23E0-4621-A2DC-C5F7E8DE6DEFQ38889450-BBBB7840-EC35-4A50-8BD0-5FFD9D7C4F0EQ39251409-20D1E3B5-509B-4252-ADCF-4AEE66E523F7Q39923159-B5F241C7-B997-4379-8DE0-0F7C2F4FF42CQ42653763-9B6942E7-B6B1-4856-9D93-2EF793EE5094Q44326438-4BD6DB53-EFD6-4998-B3B7-A0327C3A57D6Q44588435-F300C2C8-0DEE-4C90-A621-A88CA6746A04Q46442389-0875C845-C93D-4A7B-836E-02A3C64871CEQ46572343-3C2629D3-BB91-4471-85C1-CA6FD7F90325Q46827382-E1DDB1B4-C012-4045-A339-15800F5DDE9AQ53860656-A1A40F17-B314-4002-9648-A481BC5A914E
P2860
Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Chronic daily headache prophyl ...... ed, multicenter outcome study.
@en
Chronic daily headache prophyl ...... ed, multicenter outcome study.
@nl
type
label
Chronic daily headache prophyl ...... ed, multicenter outcome study.
@en
Chronic daily headache prophyl ...... ed, multicenter outcome study.
@nl
prefLabel
Chronic daily headache prophyl ...... ed, multicenter outcome study.
@en
Chronic daily headache prophyl ...... ed, multicenter outcome study.
@nl
P2093
P2860
P1433
P1476
Chronic daily headache prophyl ...... ed, multicenter outcome study.
@en
P2093
Alvin E Lake
Deborah T Cantrell
Jeffery R White
Joel R Saper
Paul K Winner
P2860
P304
P356
10.1046/J.1526-4610.2002.02122.X
P577
2002-06-01T00:00:00Z